Social Media Ideas for Biopharma

<![CDATA[A Steadying Trajectory: Biopharma Review and Outlook]]>

<![CDATA[Building Biopharma Manufacturing for Speed, Scale, and Flexibility]]>

<![CDATA[Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTe...

In Massachusetts, Latest Annual Snapshot Shows a Tale of Two Biopharmas

The job contraction, according to MassBio, reflected pipeline reprioritization by biopharma giants plus contraction by smaller companies, with R&D jobs dropping significantly b...

<![CDATA[M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to...

Merck’s new BioReliance® Facility in Darmstadt: supporting biologics development and commercialization in Europe

Merck’s new BioReliance® Facility in Darmstadt, Germany, will support biologics testing, GMP release testing and stability studies in Europe. The post Merck’s new BioReliance® Faci...

<![CDATA[Roundup: Nanexa, Earendil Labs, and Atavistik Bio Enter Platform Deals with Novo Nordisk, Genentech, and Roc...

<![CDATA[Roundup: Orbis Enters $1.4 Billion Partnership with Novo, Dualitas Therapeutics Enters Research collaboratio...

<![CDATA[The Agentic AI Revolution in Biopharma]]>

<![CDATA[Transformative Commercialization for New Biopharma Entrants: Ensuring Success With Capital and Time Efficien...

<![CDATA[Your Questions Answered: The Biggest Pharma and Biotech Stories This Week]]>

Samsung Biologics Signs $262 Million Manufacturing Agreement with European Pharma Firm

Alongside decisions involving capacity expansion, officials at Samsung Biologics announced that the company is pursuing opportunities to broaden its portfolio and address an increa...

<![CDATA[Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals]]>

<![CDATA[What Executives and Investors Are Looking for in Pharma Companies]]>

<![CDATA[M&A Roundup: Lisata Therapeutics Acquires Marea Therapeutics, mAbxience Enters Collaboration with Sandoz...

<![CDATA[Omnideployment: The Future of Pharmaceutical Commercialization]]>

Navigating A Key Inflection Point In Biosimilar Sector M&A

As biosimilar mergers and acquisitions gain notice amid U.S. Food and Drug Administration reforms, a maturing patent framework and a looming patent cliff, companies diversifying in...

<![CDATA[Roundup: AbbVie & Iambic Enter Ai Drug Discovery Collaboration, Telix Merges with ITM ]]>

GBI Biomanufacturing Set to Launch SmartScale GMP Solutions

Many early-stage drug developers need a more efficient path to obtaining the GMP material required to reach the clinic. SmartScale was designed to help close that gap. The post GBI...

New TU Dublin apprenticeship aims to tackle skills gap in biopharma sector

Employment in Ireland's biopharmaceutical sector grew by more than 60pc between 2016 and 2022, according to the course’s operators. Read more: New TU Dublin apprenticeship aims to...

<![CDATA[Licensing Roundup: Biohaven & SK Biopharmaceuticals Enter Deal for BHV-7000, Haisco License’s Sentivera...

Nu-Tek Brings Topic of Raw-Material Risk to BPI

Nu-Tek BioSciences will use BPI East to highlight animal-origin-free peptones and hydrolysates designed to strengthen media consistency, reduce raw-material risk, and support more...

<![CDATA[Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing ]]>

<![CDATA[A Leadership Call to Action for Biotech]]>